4503:TYO
Astellas Pharma Inc
Â¥2,280.50
arrow_downward
-0.98%(-22.50) 1D
Sep 8, 3:30:00 PM GMT+9 · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4503...
Open
Â¥2,287
High
Â¥2,294
Low
Â¥2,270
Mkt. cap
4.13T
Avg. vol.
6.48M
Volume
3.78M
Dividend
3.42%
Quarterly dividend
Â¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
11.20
52-wk high
Â¥2,717
52-wk low
Â¥1,558
EPS
Â¥204
Shares outstanding
1.92B
No. of employees
14K
Open
Â¥2,287
High
Â¥2,294
Low
Â¥2,270
Mkt. cap
4.13T
Avg. vol.
6.48M
Volume
3.78M
Dividend
3.42%
Quarterly dividend
Â¥20
Ex-dividend date
Sep 29, 2026
P/E ratio
11.20
52-wk high
Â¥2,717
52-wk low
Â¥1,558
EPS
Â¥204
Shares outstanding
1.92B
No. of employees
14K
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma Inc
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com